查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012825

Arthroscopy Devices Market by Product Type, Visualization Systems, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，關節鏡醫療設備市場價值將達到 73 億美元，到 2026 年將成長至 79.1 億美元，到 2032 年將達到 138.8 億美元，複合年成長率為 9.60%。

主要市場統計數據
基準年 2025 73億美元
預計年份：2026年 79.1億美元
預測年份 2032 138.8億美元
複合年成長率 (%) 9.60%

關節鏡檢查設備市場の基礎、臨床的促進要因、患者の需要パターン、および医療意思決定者向けの戦略的優先事項に関する簡潔な概要

低侵襲ソリューションへの需要が臨床現場や調達決定に引き続き影響を与える中、關節鏡検査用機器は現代の整形外科において依然として中心的な役割を果たしています。本概要では、基本的な臨床的促進要因、利害相關人員の新たな優先事項、および機器メーカー、病院システム、外来診療提供者が戦略的選択を行っている業務上の背景について概説します。手術件数の増加、早期回復への重視、および特定の手術が外来手術センターへ移行していることは、關節鏡検査用器具および画像診断システムの競合情勢と業務環境を再構築しつつあります。

可視化技術の相乗効果から器具の革新、価値に基づく医療への統合に至るまで、關節鏡診療を再構築する変革的な技術的変化の探求

技術的および構造的な変化の波が、あらゆる医療現場における關節鏡検査の実施方法を変革しつつあります。可視化技術の進歩により、高解像度かつ統合されたワークフローが可能となり、手術時間の短縮と術中意思決定の向上を実現しています。同時に、洗練されたシェーバーやグラスパから、専用設計のパンチやリトラクターに至るまでの器具の革新により、手術の精度が向上し、軟部組織への損傷が軽減され続けています。こうした変化に伴い、交差汚染のリスクを軽減しつつ、滅菌管理を簡素化するように設計された、使い捨ておよびハイブリッド使用の器具戦略の採用が拡大しています。

最近の米国の関税措置が、サプライチェーン、籌資策略、および国境を越えた醫療設備調達動向に及ぼす累積的な影響の評価

米国で導入された最近の関税措置は、關節鏡用醫療設備のサプライチェーン全体に、業務上および戦略上の連鎖的な対応を引き起こしています。輸入関税の引き上げや関連する政策変更は、総コストを上昇させ、購入者に籌資策略の再評価を促すことで、調達選択の枠組みに影響を与えています。このような環境下において、メーカーや經銷商は、利益率と競争上の優位性を維持するために、コスト要因に関する透明性を優先しつつ、代替的な調達体制や契約上の保護策を模索しています。

深入的細分分析揭示了產品、視覺化、應用、最終用戶和銷售管道的趨勢，從而支援商業化和臨床部署。

セグメンテーション分析は、臨床ニーズ、購買行動、技術的差別化が交差する点を理解するための体系的な觀點を提供します。製品タイプに基づき、市場はグラスパ、パンチ、レトラクター、シザーズ、シェーバーの各カテゴリーで調査されており、これらのカテゴリーからは明確な導入パターンが浮かび上がっています。すなわち、手術時間を短縮し、軟部組織の管理を容易にする器具は、高回転の診療現場でより強く受け入れられている一方、特殊なツールは複雑な重組手術において依然として重要な役割を果たしています。視覺化系統に基づいて、市場はカメラ、光源、モニター、スコープに分類して調査されており、これらのコンポーネント間の統合により、画質、人間工学、および記録ワークフローを最適化するバンドルソリューションへの需要が高まっています。

南北アメリカ、欧州,中東,アフリカ、アジア太平洋地域における成長要素、償還環境、インフラ整備状況を統合した地域別戦略的展望

地域ごとの動向は、關節鏡検査用機器の規制、償還、および普及の軌跡に強力な影響を及ぼしています。南北アメリカでは、確立された償還経路と成熟した病院インフラが、統合型可視化プラットフォームやプレミアムな器具ラインを後押ししている一方、外来診療部門の急速な拡大により、コンパクトでコスト効率の高いシステムに対する高い需要が局部的に生じています。対照的に、欧州,中東,アフリカ地域では、公共調達モデルの多様性、変動する償還制度、民間セクターによる投資の局部的な存在といった、不均一な状況が見られます。この多様性は、臨床的エビデンスと彈性價格設定,サービスモデルを組み合わせた、適応性の高い商業性的アプローチを有利にしています。

一份競爭情報概覽，重點介紹領先醫療設備製造商的能力、夥伴關係趨勢、差異化策略和創新重點。

關節鏡分野における競合の動態は、規模、臨床的信頼性、そして専門的なイノベーションのバランスを反映しています。大規模プラットフォーム志向の企業は、統合された画像診断技術、手術器具のポートフォリオ、アフターマーケット,サービスを活用して、病院システムや外来手術センター（ASC）との長期的な関係を構築しています。一方、小規模な専門企業は、特定の製品イノベーション、低コストの製品提供、あるいはニッチな臨床的差別化を通じて競争することが多いです。画像診断プロバイダーと手術器具メーカー間の提携はますます一般的になっており、企業間のコラボレーションにより、互通性の向上や、大手プロバイダーとの一括調達交渉が加速しています。

業界リーダーが規制の変化に対応し、サプライチェーンを最適化し、臨床導入を加速させ、永續な成長を推進するための実践的な提言

業界リーダーは、進化する臨床および政策環境に合わせて、製品開発、サプライチェーンのレジリエンス、市場投入戦略を調整するための断固たる措置を講じるべきです。第一に、サプライヤーネットワークの多様化やニアショアリング、あるいは地域的な製造夥伴關係の追求により、関税変動への曝露を軽減し、需要変動への應對力を高めることができます。第二に、臨床記録、トレーニング、およびアウトカム測定をサポートする統合型可視化およびデータプラットフォームへの投資は、支払者や医療提供者との価値に基づく対話を強化することになります。

概述了高度透明的調查方法，詳細介紹了資料來源、相關人員訪談、分析框架和檢驗程序，以確保獲得嚴謹的見解。

本分析は、主要な利害相關人員との対話、体系的な二次文献レビュー、および方法論的三角測量（トライアングレーション）を組み合わせた混合手法（ミックスド,メソッド）による研究アプローチに基づいています。一次データとしては、外科医、調達負責人、臨床エンジニア、流通部門の幹部に対する詳細なインタビューを行い、実務上の意思決定基準、ワークフロー上の制約、およびサプライヤー評価を把握しました。二次文献レビューでは、査読付き臨床文献、規制ガイダンス文書、および公開された政策発表を網羅し、一次インタビューで観察された臨床およびコンプライアンスの動向を檢驗しました。

進化する關節鏡検査の動向に対応する臨床医、保険者、メーカー、および調達チームに向けた戦略的示唆をまとめた結論的な統合

サマリーでは、關節鏡檢查設備の市場環境は、並行する技術の進歩、医療提供環境の変化、そして貿易,調達ダイナミクスの進化によって再構築されつつあります。視認性の向上、器具の洗練、手術全期ワークフローのデジタル化は、臨床面での差別化と業務効率化に向けた新たな道を開いています。同時に、関税の変更や地域ごとの規制の相違といった外部要因により、メーカーや医療システムは、より強靭なサプライチェーンの実践と、より適応性の高い經營模式を採用することが求められています。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNVポジショニングマトリックス, 2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 業界エコシステムとバリューチェーン分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • コンシューマー洞察とエンドユーザー觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 規制コンプライアンスと標準フレームワーク
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 米国の関税の累積的な影響, 2025

第7章：人工智慧的累積影響，2025年

第8章關節鏡用機器市場：製品タイプ別

  • 關節鏡
  • 體液管理系統
  • 刮鬍系統
  • 高周波（RF）アブレーションシステム
  • 視覺化系統

第9章關節鏡用機器市場視覺化系統別

  • 相機
  • 光源
  • 監視器
  • 範圍

第10章：關節鏡設備市場：依應用領域分類

  • 踝
  • 彎頭
  • 髖關節
  • 膝蓋
  • 肩膀
  • 手腕

第11章關節鏡用機器市場：エンドユーザー別

  • 醫院及門診手術中心
  • 整形外科診所

第12章關節鏡用機器市場：銷售管道別

  • 直銷
  • 銷售代理
  • 線上銷售

第13章：關節鏡設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章關節鏡用機器市場：グループ別

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：關節鏡設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國關節鏡設備市場

第17章：中國關節鏡設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • ハーフィンダール,ハーシュマン指数（HHI）
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • Bioventus LLC
  • Cannuflow, Inc.
  • CONMED Corporation
  • DJO Global, Inc.
  • EndoMed Systems GmbH
  • GPC Medical Ltd.
  • Henke Sass Wolf GmbH
  • Henke-Sass, Wolf GmbH
  • Hoya Corporation
  • Johnson & Johnson
  • JOIMAX GmbH
  • Karl Storz SE & Co. KG
  • MEDICON eG
  • Medicon Health Care Private Limited
  • MedShape, Inc.
  • Richard Wolf GmbH
  • Richard Wolf GmbH
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Sklar Surgical Instruments
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-4364D48956D8

The Arthroscopy Devices Market was valued at USD 7.30 billion in 2025 and is projected to grow to USD 7.91 billion in 2026, with a CAGR of 9.60%, reaching USD 13.88 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.30 billion
Estimated Year [2026] USD 7.91 billion
Forecast Year [2032] USD 13.88 billion
CAGR (%) 9.60%

Concise introduction to arthroscopy device market fundamentals, clinical drivers, patient demand patterns, and strategic priorities for healthcare decision-makers

Arthroscopy devices remain central to modern orthopedics as demand for minimally invasive solutions continues to influence clinical practice and procurement decisions. This introduction outlines the fundamental clinical drivers, emerging stakeholder priorities, and the operational context in which device manufacturers, hospital systems, and ambulatory providers are making strategic choices. Increasing procedural volumes, an emphasis on faster recovery pathways, and the shift of selected procedures to ambulatory surgical centers are reshaping the competitive and operational landscape for arthroscopy instrumentation and visualization systems.

Consequently, decision-makers must balance clinical performance, device ergonomics, and total cost of ownership when evaluating technology adoption. The convergence of improved imaging, refined instrumentation, and evolving reimbursement frameworks is prompting multidisciplinary teams to re-evaluate supplier relationships and capital deployment strategies. As a result, manufacturers and service providers are refining their value propositions to address not only clinical outcomes but also throughput, training, and lifecycle support requirements.

Exploration of transformative technological shifts reshaping arthroscopy practice, from visualization synergies to instrument innovation and value-based care integration

A wave of technological and structural change is transforming how arthroscopy is delivered across care settings. Advances in visualization are enabling higher-resolution, integrated workflows that shorten procedure times and enhance intraoperative decision-making. At the same time, instrument innovation-ranging from refined shavers and graspers to purpose-built punches and retractors-continues to improve procedural precision and reduce soft-tissue trauma. These shifts are accompanied by growing adoption of disposable and hybrid-use instrument strategies designed to mitigate cross-contamination risk while simplifying sterilization logistics.

Moreover, digital convergence is creating new opportunities for system-level efficiency. Integration of imaging, analytics, and procedural documentation into unified platforms is facilitating value-based care conversations between providers and payers. In parallel, the transition of selected procedures to ambulatory surgical centers is driving demand for compact, cost-effective systems with rapid turn-up times and straightforward maintenance. Taken together, these transformative shifts are not only technological but also operational, requiring manufacturers and health systems to coordinate across clinical, procurement, and IT functions to capture the full benefits.

Assessment of the cumulative implications of recent United States tariff actions on supply chains, procurement strategies, and cross-border device sourcing dynamics

Recent tariff measures introduced in the United States have produced a cascade of operational and strategic responses across arthroscopy device supply chains. Increased import levies and related policy changes influence procurement choice architecture by elevating landed costs and prompting buyers to re-evaluate sourcing strategies. In this environment, manufacturers and distributors are prioritizing transparency around cost drivers while exploring alternative sourcing arrangements and contractual protections to preserve margin and competitive positioning.

From a practical perspective, the cumulative impact of tariff-related disruption has accelerated regionalization efforts and encouraged investments in nearshore manufacturing and assembly. At the same time, procurement teams are negotiating extended lead times and contingency stock arrangements to maintain continuity of care. For device suppliers, the environment underscores the importance of flexible manufacturing, diversified supplier bases, and robust trade-compliance capabilities. Importantly, strategic dialogue between commercial teams and institutional purchasers is becoming more frequent as stakeholders align on risk-sharing mechanisms and long-term supply resilience.

Insightful segmentation analysis revealing product, visualization, application, end user, and sales channel dynamics that inform commercialization and clinical adoption

Segmentation analysis offers a structured lens for understanding where clinical need, purchasing behavior, and technological differentiation intersect. Based on Product Type, market is studied across Graspers, Punches, Retractors, Scissors, and Shavers, and these categories reveal distinct adoption patterns: instruments that reduce procedure time and facilitate soft-tissue management demonstrate stronger uptake in high-throughput settings, while specialized tools maintain relevance in complex reconstructions. Based on Visualization Systems, market is studied across Cameras, Light Sources, Monitors, and Scopes, and integration across these components is driving demand for bundled solutions that optimize image quality, ergonomics, and documentation workflows.

Further nuance emerges when considering clinical application. Based on Application, market is studied across Ankle, Elbow, Hip, Knee, Shoulder, and Wrist, and each anatomical focus presents unique instrumentation and visualization requirements that influence product development priorities. Based on End User, market is studied across Hospitals And Ambulatory Surgical Centers and Orthopedic Clinics, and the differential capital constraints, throughput expectations, and staffing models across these settings shape procurement criteria. Finally, Based on Sales Channel, market is studied across Direct Sales, Distributors, and Online Sales, and channel dynamics materially affect time-to-adoption, aftermarket support expectations, and margin structures. Together, these segmentation lenses inform go-to-market strategies and clinical engagement plans for product portfolios.

Regional strategic outlook synthesizing growth enablers, reimbursement landscapes, and infrastructure readiness across Americas, Europe Middle East Africa, and Asia-Pacific

Regional dynamics exert a powerful influence on regulatory, reimbursement, and adoption trajectories for arthroscopy devices. In the Americas, established reimbursement pathways and a mature hospital infrastructure favor integrated visualization platforms and premium instrument lines, while the ambulatory sector's rapid expansion creates pockets of high demand for compact, cost-efficient systems. In contrast, Europe, Middle East & Africa presents a heterogeneous mix of public procurement models, variable reimbursement, and pockets of private-sector investment; this diversity favors adaptable commercial approaches that combine clinical evidence with flexible pricing and service models.

Turning to Asia-Pacific, rapid infrastructure investment, growing surgical capacity, and a rising middle class are driving demand for both cost-competitive disposables and advanced imaging technologies. Across all regions, regulatory oversight, local manufacturing incentives, and supply chain logistics remain defining factors. Consequently, manufacturers must tailor product specifications, service offerings, and commercial tactics to align with each region's reimbursement atmosphere, clinical practice patterns, and distribution ecosystems.

Competitive intelligence snapshot highlighting company capabilities, partnership trends, differentiation strategies, and innovation focus across leading medical device players

Competitive dynamics in the arthroscopy space reflect a balance between scale, clinical credibility, and specialized innovation. Larger platform-oriented companies leverage integrated imaging, instrument portfolios, and aftermarket services to build long-term relationships with hospital systems and ASCs, while smaller specialists often compete through focused product innovation, lower-cost offerings, or niche clinical differentiation. Partnerships between imaging providers and instrument manufacturers are increasingly common, as cross-company collaboration accelerates interoperability and bundled procurement talks with large providers.

Additionally, firms that invest in surgeon education, outcomes research, and durable service contracts tend to achieve higher adoption rates, particularly when they can demonstrate improvements in throughput or reductions in total procedural cost. From a commercial perspective, companies that combine flexible channel strategies with modular product architectures are better positioned to respond to regional regulatory changes and evolving buyer preferences. Finally, aftermarket services such as instrument repair, sterilization support, and digital workflow enhancements are emerging as significant differentiators in competitive pitches.

Action-oriented recommendations for industry leaders to navigate regulatory shifts, to optimize supply chains, accelerate clinical uptake, and to drive sustainable growth

Industry leaders should take decisive steps to align product development, supply chain resilience, and go-to-market tactics with evolving clinical and policy environments. First, diversifying supplier networks and pursuing nearshoring or regional manufacturing partnerships will reduce exposure to tariff volatility and enhance responsiveness to demand fluctuations. Second, investing in integrated visualization and data platforms that support clinical documentation, training, and outcomes measurement will strengthen value-based conversations with payers and providers.

In parallel, commercial teams should refine channel strategies by combining direct engagement for large institutional accounts with distributor partnerships and selective online offerings for price-sensitive segments. Clinical evidence generation remains a priority; leaders must fund rigorous comparative studies and real-world evidence initiatives to substantiate claims about efficiency gains and improved patient outcomes. Finally, prioritizing service models that reduce total cost of ownership-such as predictable maintenance contracts, instrument lifecycle programs, and training bundles-will help sustain long-term relationships with high-value customers and capture recurring revenue opportunities.

Transparent research methodology overview detailing data sources, stakeholder interviews, analytical frameworks, and validation steps used to ensure rigorous insights

This analysis draws on a mixed-methods research approach that combined primary stakeholder engagement with systematic secondary review and methodological triangulation. Primary inputs included in-depth interviews with surgeons, procurement officers, clinical engineers, and distribution executives to capture real-world decision criteria, workflow constraints, and supplier evaluations. Secondary review encompassed peer-reviewed clinical literature, regulatory guidance documents, and open-source policy announcements to validate clinical and compliance trends observed in primary conversations.

Quantitative and qualitative findings were triangulated through iterative validation rounds, including follow-up interviews and cross-checks against regulatory filings and manufacturer technical documentation. Where relevant, scenario analysis was used to test sensitivity to policy changes and supply chain disruptions. Limitations are acknowledged: the approach emphasizes thematic rigor over exhaustive enumeration and focuses on actionable strategic insight rather than granular vendor ranking. Nevertheless, the methodological framework ensures that conclusions are grounded in practitioner experience and corroborated by authoritative sources.

Conclusive synthesis summarizing strategic implications for clinicians, payers, manufacturers, and procurement teams navigating the evolving arthroscopy landscape

In summary, the arthroscopy device landscape is being reshaped by concurrent technological advances, shifting care settings, and evolving trade and procurement dynamics. Enhanced visualization, refined instrumentation, and the digitization of perioperative workflows are creating new avenues for clinical differentiation and operational efficiency. At the same time, external forces such as tariff changes and regional regulatory variation require manufacturers and health systems to adopt more resilient supply chain practices and more adaptable commercial models.

Looking ahead, stakeholders who proactively invest in evidence generation, flexible manufacturing, and integrated service offerings will be best positioned to capture the benefits of clinical adoption while mitigating downside risk. Collaboration between clinical leaders, procurement teams, and industry partners will be essential to translate innovation into improved patient outcomes and sustainable organizational value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Arthroscopy Devices Market, by Product Type

  • 8.1. Arthroscopes
  • 8.2. Fluid Management Systems
  • 8.3. Shaver Systems
  • 8.4. Radiofrequency (RF) Ablation Systems
  • 8.5. Visualization Systems

9. Arthroscopy Devices Market, by Visualization Systems

  • 9.1. Cameras
  • 9.2. Light Sources
  • 9.3. Monitors
  • 9.4. Scopes

10. Arthroscopy Devices Market, by Application

  • 10.1. Ankle
  • 10.2. Elbow
  • 10.3. Hip
  • 10.4. Knee
  • 10.5. Shoulder
  • 10.6. Wrist

11. Arthroscopy Devices Market, by End User

  • 11.1. Hospitals And Ambulatory Surgical Centers
  • 11.2. Orthopedic Clinics

12. Arthroscopy Devices Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Sales

13. Arthroscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Arthroscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Arthroscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Arthroscopy Devices Market

17. China Arthroscopy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Arthrex, Inc.
  • 18.6. B. Braun Melsungen AG
  • 18.7. Bioventus LLC
  • 18.8. Cannuflow, Inc.
  • 18.9. CONMED Corporation
  • 18.10. DJO Global, Inc.
  • 18.11. EndoMed Systems GmbH
  • 18.12. GPC Medical Ltd.
  • 18.13. Henke Sass Wolf GmbH
  • 18.14. Henke-Sass, Wolf GmbH
  • 18.15. Hoya Corporation
  • 18.16. Johnson & Johnson
  • 18.17. JOIMAX GmbH
  • 18.18. Karl Storz SE & Co. KG
  • 18.19. MEDICON eG
  • 18.20. Medicon Health Care Private Limited
  • 18.21. MedShape, Inc.
  • 18.22. Richard Wolf GmbH
  • 18.23. Richard Wolf GmbH
  • 18.24. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18.25. Sklar Surgical Instruments
  • 18.26. Smith & Nephew plc
  • 18.27. Stryker Corporation
  • 18.28. Wright Medical Group N.V.
  • 18.29. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTHROSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTHROSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ARTHROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SHAVER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SHAVER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SHAVER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY RADIOFREQUENCY (RF) ABLATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY RADIOFREQUENCY (RF) ABLATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY RADIOFREQUENCY (RF) ABLATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ANKLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ANKLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ANKLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ELBOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ELBOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ELBOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY HIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY HIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY HIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY WRIST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY WRIST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY WRIST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY HOSPITALS AND AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY HOSPITALS AND AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY HOSPITALS AND AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ARTHROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. GCC ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GCC ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. GCC ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 126. GCC ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. GCC ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. GCC ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. G7 ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. G7 ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. G7 ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 144. G7 ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. G7 ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. G7 ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. NATO ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. NATO ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NATO ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 150. NATO ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. NATO ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. NATO ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA ARTHROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)